Impact of Social contagion on Physician use of unproven cancer interventions
社会传染对医生使用未经证实的癌症干预措施的影响
基本信息
- 批准号:8791473
- 负责人:
- 金额:$ 50.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-19 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAdoptedAdoptionAffectBehaviorBreastCancer InterventionCaringCharacteristicsClinicalCommunicationComplexDiagnosticDiagnostic radiologic examinationDiffuseDiffusionDiffusion of InnovationDirect CostsEvaluationGoalsGuidelinesHealthHealth systemImageIndividualInternetInterventionInvestigationLightLinkMagnetic Resonance ImagingMalignant NeoplasmsMedicalMedicareMetastatic Neoplasm to the BoneMethodsModelingNatureOutcomePatient CarePatientsPatternPatterns of CarePhysician&aposs RolePhysiciansPoliciesPopulationPositron-Emission TomographyPropertyProviderRadiationRadiation OncologistRadiation therapyRoleShapesSocial ConceptsSocial ImpactsSocial SciencesStructureSystemTechnologyTestingTherapeutic Radiology specialtyTimeWomanWorkbehavior changebehavior influencebeneficiarycancer careclinical careclinical practicecontagioncostdriving behavioreconomic impactinnovationmalignant breast neoplasmnew technologynovelnovel strategiespalliativepanaceapaymentpeerpublic health relevancesocialstandard of care
项目摘要
DESCRIPTION (provided by applicant): Efforts to align cancer care with the best available medical evidence have largely focused on disseminating guidelines, enhancing physician-patient communication, and revising payment schema. Although these are critical strategies, it is possible that another major influence on physician behavior has been overlooked - what if the practice of a physician's peers was a major determinant of whether she or he adopts one new cancer intervention or abandons another? We propose a novel investigation of the impact of physicians and physician patient-sharing networks on the adoption and abandonment of cancer interventions. Physician networks are groups of physicians who work with one another either directly or indirectly, through shared patients. New cancer management approaches could diffuse through such networks via social contagion, whereby ideas and behaviors spread through interconnected groups of people. It is particularly timely to explore new constructs that shape the delivery of cancer care, as the rapid diffusion of expensive, unproven, and sometimes ineffective cancer interventions poses a significant threat to the sustainability of the cancer car system and to the health of individual patients. For instance, the use of advanced imaging tests (AITs) such as PET scans and MRI for women with breast cancer has increased substantially over the past decade, despite little evidence supporting their use. Further, once an intervention has diffused into practice and become a standard of care, it can remain widely used even when there is evidence that it provides limited or no incremental benefit compared to less expensive or burdensome alternatives. For example, radiation oncologists have been reluctant to abandon the lengthier and more expensive "standard" courses of radiation for breast cancer, despite evidence that shorter courses yield similar outcomes. To address these concerns, we will focus on Medicare beneficiaries undergoing breast cancer care. We aim to (1) construct physician patient-sharing networks; (2) assess the impact of physicians and social contagion on the early adoption of AITs and the early abandonment of more costly and inconvenient longer-course radiotherapy; (3) identify physician and physician network characteristics associated with early adoption or abandonment of interventions; and (4) assess the population-level impact of physicians' adoption and abandonment of these interventions in terms of costs, care patterns, and outcomes, across physicians. Within any complex system, it is critical to understand factors that drive the behavior of individuals. A rigorous analysis of the complex web of physician and patient interactions in cancer care can not only provide a rich understanding of how physicians influence the behavior of their peers, but also identify a potentially powerful lever for inducing physicians to abandon ineffective interventions or discourage the use of unproven ones (Provocative Question E-3).
描述(由申请人提供):将癌症护理与最佳医学证据相结合的努力主要集中在传播指南,加强医患沟通和修改支付方案上。虽然这些都是关键的策略,但可能对医生行为的另一个主要影响被忽视了-如果医生的同行的做法是她或他是否采用一种新的癌症干预或放弃另一种的主要决定因素呢?我们提出了一个新的调查医生和医生病人共享网络的影响,采用和放弃癌症干预措施。医生网络是一群医生,他们通过共享病人直接或间接地相互合作。新的癌症管理方法可以通过社会传染通过这样的网络传播,思想和行为通过相互联系的人群传播。 探索塑造癌症护理交付的新结构是特别及时的,因为昂贵的,未经证实的,有时无效的癌症干预措施的快速扩散对癌症护理系统的可持续性和个体患者的健康构成了重大威胁。例如,在过去的十年中,先进的成像测试(AIT),如PET扫描和MRI,在乳腺癌患者中的使用大幅增加,尽管几乎没有证据支持它们的使用。此外,一旦干预措施扩散到实践中并成为护理标准,即使有证据表明与较便宜或负担较重的替代品相比,它提供的益处有限或没有增量,它也可以继续广泛使用。例如,放射肿瘤学家一直不愿意放弃乳腺癌放射治疗的更快和更昂贵的“标准”疗程,尽管有证据表明较短的疗程会产生类似的结果。 为了解决这些问题,我们将重点关注接受乳腺癌护理的医疗保险受益人。我们的目标是(1)构建医生和患者共享网络;(2)评估医生和社会传染对早期采用AIT和早期放弃更昂贵和更不方便的长期放疗的影响;(3)确定与早期采用或放弃干预措施相关的医生和医生网络特征;以及(4)评估医生采用和放弃这些干预措施在成本、护理模式和结果方面对医生的人群水平影响。在任何复杂的系统中,了解驱动个体行为的因素至关重要。对癌症护理中医生和患者互动的复杂网络进行严格分析,不仅可以丰富地了解医生如何影响同行的行为,而且还可以确定一个潜在的强大杠杆,用于诱导医生放弃无效的干预措施或阻止使用未经证实的干预措施(挑衅性问题E-3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cary P. Gross其他文献
Laparoscopic colon resection for cancer is not associated with fewer hospital-based encounters following discharge
- DOI:
10.1016/j.jamcollsurg.2012.06.264 - 发表时间:
2012-09-01 - 期刊:
- 影响因子:
- 作者:
Dallas G. Hansen;Justin P. Fox;Cary P. Gross;John S. Bruun - 通讯作者:
John S. Bruun
Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses
- DOI:
10.1016/j.jss.2020.05.095 - 发表时间:
2020-12-01 - 期刊:
- 影响因子:
- 作者:
Kathleen M. O'Neill;Raymond A. Jean;Cary P. Gross;Robert D. Becher;Rohan Khera;Javier Valero Elizondo;Khurram Nasir - 通讯作者:
Khurram Nasir
Current Attitudes and Practices Around Screening Mammography Among Women in the United States: Results of a National Survey
- DOI:
10.1007/s11606-020-05892-1 - 发表时间:
2020-06-15 - 期刊:
- 影响因子:4.200
- 作者:
Mia Djulbegovic;Jenerius Aminawung;Jessica R. Hoag;Kelly A. Kyanko;Xiao Xu;Susan H. Busch;Cary P. Gross - 通讯作者:
Cary P. Gross
Recruiting Vulnerable Populations into Research: A Systematic Review of Recruitment Interventions
- DOI:
10.1007/s11606-007-0126-3 - 发表时间:
2007-03-21 - 期刊:
- 影响因子:4.200
- 作者:
Stacy J. UyBico;Shani Pavel;Cary P. Gross - 通讯作者:
Cary P. Gross
Diagnosis of cancer as an emergency: a critical review of current evidence
癌症诊断作为紧急情况:对当前证据的批判性回顾
- DOI:
10.1038/nrclinonc.2016.155 - 发表时间:
2016-10-11 - 期刊:
- 影响因子:82.200
- 作者:
Yin Zhou;Gary A. Abel;Willie Hamilton;Kathy Pritchard-Jones;Cary P. Gross;Fiona M. Walter;Cristina Renzi;Sam Johnson;Sean McPhail;Lucy Elliss-Brookes;Georgios Lyratzopoulos - 通讯作者:
Georgios Lyratzopoulos
Cary P. Gross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cary P. Gross', 18)}}的其他基金
Health System and Contextual Factors Associated with Racial Equity in Lung Cancer Care
与肺癌护理中种族公平相关的卫生系统和背景因素
- 批准号:
10708007 - 财政年份:2022
- 资助金额:
$ 50.12万 - 项目类别:
Incarceration and Cancer-Related Outcomes (ICRO)
监禁和癌症相关结果 (ICRO)
- 批准号:
10439790 - 财政年份:2018
- 资助金额:
$ 50.12万 - 项目类别:
Incarceration and Cancer-Related Outcomes (ICRO)
监禁和癌症相关结果 (ICRO)
- 批准号:
10223233 - 财政年份:2018
- 资助金额:
$ 50.12万 - 项目类别:
Impact of Social contagion on Physician use of unproven cancer interventions
社会传染对医生使用未经证实的癌症干预措施的影响
- 批准号:
9143060 - 财政年份:2014
- 资助金额:
$ 50.12万 - 项目类别:
Impact of Social contagion on Physician use of unproven cancer interventions
社会传染对医生使用未经证实的癌症干预措施的影响
- 批准号:
9315785 - 财政年份:2014
- 资助金额:
$ 50.12万 - 项目类别:
Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers
常见癌症医疗保险患者放射治疗的使用和结果
- 批准号:
8048961 - 财政年份:2010
- 资助金额:
$ 50.12万 - 项目类别:
Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers
常见癌症医疗保险患者放射治疗的使用和结果
- 批准号:
8257069 - 财政年份:2010
- 资助金额:
$ 50.12万 - 项目类别:
Multimorbidity and Cancer Screening: Achieving Patient Understanding
多重发病和癌症筛查:实现患者理解
- 批准号:
7791003 - 财政年份:2009
- 资助金额:
$ 50.12万 - 项目类别:
Multimorbidity and Cancer Screening: Achieving Patient Understanding
多重发病和癌症筛查:实现患者理解
- 批准号:
7930592 - 财政年份:2009
- 资助金额:
$ 50.12万 - 项目类别:
Multimorbidity and Screening Colonoscopy: A Framework for Patients and Policy
多发病和筛查结肠镜检查:患者和政策框架
- 批准号:
7678587 - 财政年份:2008
- 资助金额:
$ 50.12万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 50.12万 - 项目类别:














{{item.name}}会员




